Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Christiane Pott, Martin Dreyling, Sebastian Böttcher et al.|Blood|2009

Cited by 269